ABOUT US

At Genedian Australia, our mission is to advance the integration of innovative diagnostic techniques to safeguard global health. With a steadfast focus on the In Vitro Diagnostics (IVD) industry, we drive the development and implementation of cutting-edge diagnostic technologies and products. Our unwavering commitment is to emerge as a global leader in providing comprehensive medical diagnostic solutions through scientific and technological innovation.

We continually refine our comprehensive industrial framework encompassing the continuum of "from diagnosis to treatment" in the R&D and manufacturing of in vitro diagnostic instruments and reagents. By partnering with third-party manufacturers, Genedian Australia has developed a diverse array of rapid test products for clinical chemistry, immunoassays, molecular diagnostics, microbiology, self-testing, and point-of-care testing (POCT).

Our robust diagnostic product portfolio is anchored in six key disease areas:

·     Digestive and metabolic diseases

·     Cardiovascular and cerebrovascular conditions

·     Reproductive health

·     Central nervous system disorders

·     Infectious diseases

This comprehensive approach enables us to build an efficient automated pipeline while also maintaining a focused POCT product suite, thereby enhancing our ability to deliver innovative, high-quality diagnostic tools that meet the evolving needs of healthcare professionals Internationally.